134 related articles for article (PubMed ID: 10491020)
1. Expression of membrane type 1-matrix metalloproteinase in laryngeal carcinoma.
Du B; Wang P; Guo X; Du B
Pathol Oncol Res; 1999; 5(3):214-7. PubMed ID: 10491020
[TBL] [Abstract][Full Text] [Related]
2. [Morphological tumor front grading and matrix metalloproteinases type I expression as a prognostic parameter of the presence of lymph node micrometastases in laryngeal carcinoma].
Lukomski M; Lewy-Trenda I; Stasikowska O; Durko M; Starska K
Otolaryngol Pol; 2007; 61(5):805-10. PubMed ID: 18552024
[TBL] [Abstract][Full Text] [Related]
3. Expression of collagenase-3 (matrix metalloproteinase-13) in human gastric cancer.
Elnemr A; Yonemura Y; Bandou E; Kinoshita K; Kawamura T; Takahashi S; Tochiori S; Endou Y; Sasaki T
Gastric Cancer; 2003; 6(1):30-8. PubMed ID: 12673424
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of expression of membrane type 1 matrix metalloproteinase and matrix metalloproteinase-2 in human head and neck squamous cell carcinoma.
Imanishi Y; Fujii M; Tokumaru Y; Tomita T; Kanke M; Kanzaki J; Kameyama K; Otani Y; Sato H
Hum Pathol; 2000 Aug; 31(8):895-904. PubMed ID: 10987249
[TBL] [Abstract][Full Text] [Related]
5. Expression of membrane-type 1, 2, and 3 matrix metalloproteinases messenger RNA in ovarian carcinoma cells in serous effusions.
Davidson B; Goldberg I; Berner A; Nesland JM; Givant-Horwitz V; Bryne M; Risberg B; Kristensen GB; Tropé CG; Kopolovic J; Reich R
Am J Clin Pathol; 2001 Apr; 115(4):517-24. PubMed ID: 11293899
[TBL] [Abstract][Full Text] [Related]
6. Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human oral squamous cell carcinomas: implications for lymph node metastasis.
Shimada T; Nakamura H; Yamashita K; Kawata R; Murakami Y; Fujimoto N; Sato H; Seiki M; Okada Y
Clin Exp Metastasis; 2000; 18(2):179-88. PubMed ID: 11235994
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of matrix metalloproteinase-20 overexpression in laryngeal squamous cell carcinoma.
Liu Y; Li Y; Liu Z; Zhang L; Anniko M; Duan M
Acta Otolaryngol; 2011 Jul; 131(7):769-73. PubMed ID: 21466263
[TBL] [Abstract][Full Text] [Related]
8. Expression of mRNA for membrane-type 1, 2, and 3 matrix metalloproteinases in human laryngeal cancer.
Sun YN; Li Y
Chin Med Sci J; 2004 Sep; 19(3):170-3. PubMed ID: 15506641
[TBL] [Abstract][Full Text] [Related]
9. Gelatinase A, membrane type 1 matrix metalloproteinase, and extracellular matrix metalloproteinase inducer mRNA expression: correlation with invasive growth of breast cancer.
Dalberg K; Eriksson E; Enberg U; Kjellman M; Bäckdahl M
World J Surg; 2000 Mar; 24(3):334-40. PubMed ID: 10658069
[TBL] [Abstract][Full Text] [Related]
10. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
Sakata K; Shigemasa K; Nagai N; Ohama K
Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
[TBL] [Abstract][Full Text] [Related]
11. [Correlation of membrane type I matrix metalloproteinase (MT1-MMP) expression with clinicomorphological features of tumor front in squamous cell carcinoma of the larynx].
Starska K; Stasikowska O; Lukomski M; Lewy-Trenda I
Pol Merkur Lekarski; 2007 Sep; 23(135):188-91. PubMed ID: 18080692
[TBL] [Abstract][Full Text] [Related]
12. Expression of MMP-7 and MT1-MMP in oral squamous cell carcinoma as predictive indicator for tumor invasion and prognosis.
de Vicente JC; Lequerica-Fernández P; Santamaría J; Fresno MF
J Oral Pathol Med; 2007 Aug; 36(7):415-24. PubMed ID: 17617835
[TBL] [Abstract][Full Text] [Related]
13. Expression of matrix metalloproteinase 1, matrix metalloproteinase 2, and matrix metalloproteinase 9 in carcinoma of the head and neck.
Franchi A; Santucci M; Masini E; Sardi I; Paglierani M; Gallo O
Cancer; 2002 Nov; 95(9):1902-10. PubMed ID: 12404284
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of membrane-type 1-matrix metalloproteinase (MT1-MMP) production and sequential activation of progelatinase A on human squamous carcinoma cells co-cultured with human dermal fibroblasts.
Sato T; Iwai M; Sakai T; Sato H; Seiki M; Mori Y; Ito A
Br J Cancer; 1999 Jun; 80(8):1137-43. PubMed ID: 10376963
[TBL] [Abstract][Full Text] [Related]
15. [Significance of membrane type-1 matrix metalloproteinase expression in breast cancer].
Yao GY; Yang MT; Rong TH; He P
Ai Zheng; 2004 Nov; 23(11 Suppl):1482-6. PubMed ID: 15566663
[TBL] [Abstract][Full Text] [Related]
16. Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human urothelial carcinomas.
Kitagawa Y; Kunimi K; Ito H; Sato H; Uchibayashi T; Okada Y; Seiki M; Namiki M
J Urol; 1998 Oct; 160(4):1540-5. PubMed ID: 9751409
[TBL] [Abstract][Full Text] [Related]
17. Expression and tissue localization of membrane-type 1, 2, and 3 matrix metalloproteinases in human astrocytic tumors.
Nakada M; Nakamura H; Ikeda E; Fujimoto N; Yamashita J; Sato H; Seiki M; Okada Y
Am J Pathol; 1999 Feb; 154(2):417-28. PubMed ID: 10027400
[TBL] [Abstract][Full Text] [Related]
18. Expression of membrane-type matrix metalloproteinase 1 (MT1-MMP) in tumor cells enhances pulmonary metastasis in an experimental metastasis assay.
Tsunezuka Y; Kinoh H; Takino T; Watanabe Y; Okada Y; Shinagawa A; Sato H; Seiki M
Cancer Res; 1996 Dec; 56(24):5678-83. PubMed ID: 8971175
[TBL] [Abstract][Full Text] [Related]
19. E1AF expression is closely correlated with malignant phenotype of tongue squamous cell carcinoma through activation of MT1-MMP gene promoters.
Izumiyama Y; Ohiro Y; Higashino F; Yoshida K; Taguchi K; Todo S; Kohgo T; Totsuka Y; Shindoh M
Oncol Rep; 2005 Apr; 13(4):715-20. PubMed ID: 15756447
[TBL] [Abstract][Full Text] [Related]
20. Curcumin, a potential inhibitor of MMP-2 in human laryngeal squamous carcinoma cells HEp2.
Mitra A; Chakrabarti J; Banerji A; Chatterjee A; Das BR
J Environ Pathol Toxicol Oncol; 2006; 25(4):679-90. PubMed ID: 17341208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
